Trademark: 98044278
Status Date
Tuesday, March 19, 2024
Filing Date
Thursday, June 15, 2023
Published for Opposition
Tuesday, January 23, 2024
5 Pharmaceutical and medical preparations for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases; pharmaceutical therapeutics for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases; protein degraders being pharmaceutical preparations for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases
42 Research and development of therapeutic drugs for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases; research and development of therapeutic antibodies and pharmaceuticals; research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; development of pharmaceutical preparations and medicines; pharmaceutical drug development services and drug discovery services; medical research for development of therapeutic modalities for treatment of diseases
Mar 19, 2024
Noa E-Mailed - Sou Required From Applicant
Jan 23, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 23, 2024
Published For Opposition
Jan 3, 2024
Notification Of Notice Of Publication E-Mailed
Dec 14, 2023
Approved For Pub - Principal Register
Dec 14, 2023
Examiner's Amendment Entered
Dec 14, 2023
Notification Of Examiners Amendment E-Mailed
Dec 14, 2023
Examiners Amendment E-Mailed
Dec 14, 2023
Examiners Amendment -Written
Dec 8, 2023
Assigned To Examiner
Jul 19, 2023
New Application Office Supplied Data Entered
Jun 19, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
